1st Quarter - Report

VIZIENT, INC. for VIZIENT INC

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Not-for-Profit Hospital Tax Exemption - monitored discussions in Congress regarding possible changes to hospital tax-exemption and community benefit requirements to require minimum charity care levels to maintain tax-exempt status.

LobbyistCovered position, as disclosed
CHELSEA ARNONE —
SHOSHANA KRILOW —
STEVEN RIXEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Health Issues HCR

Hospital Group Purchasing - Advocated in support of hospital group purchasing organizations and maintaining the GPO safe harbor. Overall Hospital Quality Star Ratings System - Urged changes to the methodology of the Overall Hospital Quality Star Ratings System. 340B Drug Pricing Program - Supported maintaining adequate reimbursement for hospitals purchasing prescription drugs through the 340B Drug Pricing Program. Advocated for maintaining the current structure of the program and supported retaining the current prime vendor. Prescription Drug Pricing - Urged passage of legislation that would promote competition among prescription drug manufacturers. Supported passage of the CREATES Act (H.R. 965; S. 340). Supported passage of the FAST Generics Act (H.R. 985). Supported passage of Biologic Patent Transparency Act (S.659). Monitored ongoing Congressional discussions related modifying pharmacy benefit manager rebates and other legislation related to patents, pay-for-delay settlements and improvements to FDA resources regarding biosimilar medications. Medical Device and Hospital Cybersecurity - Monitored ongoing discussion around enhancing cybersecurity protections for medical devices and hospital networks. Supported additional resources to bolster efforts as well as regulatory flexibility that recognizes the complexity of preventing and responding to cyberattacks. Disaster Preparedness - Conducted education and outreach to describe hospital efforts and resources necessary to prepare for natural disasters and mass-casualty events.

LobbyistCovered position, as disclosed
CHELSEA ARNONE —
SHOSHANA KRILOW —
STEVEN RIXEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 659 (116th), H.R. 985 (116th), S. 340 (116th), H.R. 965 (116th)

Medicare/Medicaid MMM

Medicaid Disproportionate Share Hospital (DSH) Payments - Urged Congress to continue delay of implementation of Medicaid DSH payment cuts. ACE Kids Act (H.R. 1226, S.317) - Urged passage of ACE Kids Act to promote greater care coordination and expand Medicaid treatment options for medically complex pediatric patients. Site-neutral Payments - Opposed efforts to reduce payment rates for hospital outpatient departments. Advocated for Congress to reverse site-neutral payments cuts implemented by the Centers for Medicare and Medicaid Services in the 2019 Outpatient Prospective Payment System final rule. Resident Physician Shortage Reduction Act (S. 348) - Supported passage of the Resident Physician Shortage Reduction Act to support an increase in the number of Medicare-supported graduate medical education residents.

LobbyistCovered position, as disclosed
CHELSEA ARNONE —
SHOSHANA KRILOW —
STEVEN RIXEN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 348 (116th), S. 317 (116th), H.R. 1226 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.